Prostate cancer screening generally begins around age 50, while men at higher risk may consider starting earlier, closer to 40 or 45.

A three-point scoring system that requires nothing more than a blood count, a brief assessment of a patient’s physical ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

At Fox Chase Cancer Center, specialists consider PSA levels, biopsy results, imaging, risk group, overall health, and personal priorities when helping patients choose a course of care.

UCLA investigators present the latest radiotherapy research at the American Society for Radiation Oncology annual meeting ...

Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

Thousands of men with prostate cancer could avoid the debilitating urinary and sexual side effects of surgery, thanks to a ...

Intensity-modulated proton therapy (IMPT) allows radiation oncologists to limit the dose to organs surrounding the prostate. That property may be particularly relevant for patients with prostate ...

For men with genitourinary malignancies, such as prostate cancer, examining the external genital area is essential. While this may seem routine, it remains a crucial recommendation, as illustrated by ...

Medicus Pharma (NASDAQ:MDCX) has submitted a seamless Phase 2b/3 registration-intent protocol to the US Food and Drug ...

The Prostate Cancer Foundation (PCF) will convene leading researchers, clinicians and industry experts at its 33rd Annual Scientific Retreat, October 2–4, 2026, in Carlsbad, California. The Retreat is ...